oncology.pub rapport :   Visitez le site

Données techniques du oncology.pub

Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations. Notre service GeoIP a trouvé l'hôte oncology.pub.Actuellement, hébergé dans Singapore et son fournisseur de services est CloudFlare Inc. .

the related websites

domaine	Titre
mdlinx.com	latest medical news, healthcare conferences & clinical research trials | free bo
oncology.pub	oncology.pub - the latest clinical oncology news & research
vishyaamritsitaraepisode.com	vish ya amrit sitara latest episodes online drama - vish ya amrit sitara latest
lfhk.info	latest updates |
govtjobsnews.org	govtjobsnews.org - latest government job
apkfolks.com	apkfolks - download all latest mod apk's directly
moviesahd.com	moviesahd - msh download latest movie
usports.org	usports – latest sports news & videos
wedado.com	latest job vacancies - wedado.com find jobs in uae
drasticdsemulatorapks.com	drastic ds emulator apk download (latest version)
mnlcatalog.com	get all the latest info on your favorite goods online
bdmusic440.com	bdmusic440.com | latest all movie free download best site
clashoflightsapk.info	download clash of lights apk latest version for android |
mrsquishme.com	mr squish me – latest gadget, accessories & outdoor sport
canadiansportsmagazine.com	canadian sports magazine – latest sport news

phd-in-oncology.com atlasgeneticsoncology.org icorad.com vsnt.com otimroepmq.ca congres-medical.com 

Analyse d'en-tête HTTP

Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé cloudflare contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.

DNS

HtmlToText

oncology.pub - the latest clinical oncology news & research homepage advertisement oncology pub home oncology specialties specialities breast cancer gastrointestinal cancers genitourinary cancer gynecologic cancer innuno-oncology lung cancer renal cell carcinoma clinical sources dailymed mdedge pubmed medscape clinicaltrials.gov oncology clinical trials clinical trials: lung cancer breaking news pioneering radiotherapy machine is a ‘dream come true’: 5 questions better therapy, not earlier diagnosis, explains improved rcc survival brentuximab vendotin plus chp meets pfs endpoint in echelon-2 will quad therapy become the new standard in myeloma? will quad therapy become the new standard in myeloma? novel options for treating hairy cell leukemia novel options for treating hairy cell leukemia b-cell maturation antigen targeted in myeloma trials b-cell maturation antigen targeted in myeloma trials pazopanib is active against renal, other neoplasms of von hippel-lindau disease vaccine tx shows promise in her2-positive cancers on-site coverage of chest 2018 impower133: atezolizumab plus standard chemotherapy boosted survival in es-sclc impower133: atezolizumab plus standard chemotherapy boosted survival in es-sclc adherence to follow-up lung cancer screening not optimal pioneering radiotherapy machine is a ‘dream come true’: 5 questions ‘transformational’ results in squamous cell lung cancer dog sniffs out lung cancer, but something’s fishy breast cancer risk in type 2 diabetes related to adiposity breast cancer risk in type 2 diabetes related to adiposity lung cancer vaccine tx shows promise in her2-positive cancers 1 day ago 0 4 action points note that this study was published as an abstract and presented at a … read more » on-site coverage of chest 2018 1 day ago 0 2 impower133: atezolizumab plus standard chemotherapy boosted survival in es-sclc 1 day ago 0 0 adherence to follow-up lung cancer screening not optimal 1 day ago 0 1 breast cancer pioneering radiotherapy machine is a ‘dream come true’: 5 questions 23 hours ago 0 4 a ground-breaking new radiotherapy machine is being used in the uk. the magnetic resonance linear … read more » ‘transformational’ results in squamous cell lung cancer 2 days ago 0 0 dog sniffs out lung cancer, but something’s fishy 2 days ago 0 1 breast cancer risk in type 2 diabetes related to adiposity 2 days ago 0 1 latest news pioneering radiotherapy machine is a ‘dream come true’: 5 questions 23 hours ago 0 4 a ground-breaking new radiotherapy machine is being used in the uk. the magnetic resonance linear … read more » better therapy, not earlier diagnosis, explains improved rcc survival 1 day ago 0 4 credit improvements in therapy rather than diagnosis at an earlier stage for improved survival of … read more » brentuximab vendotin plus chp meets pfs endpoint in echelon-2 1 day ago 0 0 takeda pharmaceuticals and seattle genetics announced top-line results in the echelon-2 phase 3 trial of … read more » will quad therapy become the new standard in myeloma? 1 day ago 0 0 new york – four-drug combinations are looking promising for the treatment of multiple myeloma, though … read more » will quad therapy become the new standard in myeloma? 1 day ago 0 0 new york – four-drug combinations are looking promising for the treatment of multiple myeloma, though … read more » novel options for treating hairy cell leukemia 1 day ago 0 0 new york – ibrutinib, and now moxetumomab pasudotox, are two novel therapies that can be … read more » novel options for treating hairy cell leukemia 1 day ago 0 0 new york – ibrutinib, and now moxetumomab pasudotox, are two novel therapies that can be … read more » b-cell maturation antigen targeted in myeloma trials 1 day ago 0 0 new york – three novel treatment strategies that target b-cell maturation antigen (bcma) have shown … read more » page 1 of 42 1 2 3 4 5 » 10 20 30 ... last » recent popular comments tags heplisav-b hepatitis b vaccine in treatment na(sqrroot) ve chronic lymphocytic leukemia (cll) and cll treated with bruton s-tyrosine kinase inhibitor (btk-i) 23 hours ago genotype -phenotype correlation of pklr variants with pyruvate kinase, 2,3-diphosphglycerate and adenosine triphosphate activities in red blood cells of people with sickle cell disease 23 hours ago trial evaluating mgta-456 in patients with high-risk malignancy 23 hours ago clinical evaluation of the “nicu clinical decision support dashboard” – chmco 23 hours ago clinical evaluation of the “nicu clinical decision support dashboard” – mhsb 23 hours ago ramucirumab and atezolizumab after progression on any immune checkpoint blocker in nsclc 2 days ago 5 better therapy, not earlier diagnosis, explains improved rcc survival 1 day ago 4 pioneering radiotherapy machine is a ‘dream come true’: 5 questions 23 hours ago 4 vaccine tx shows promise in her2-positive cancers 1 day ago 4 faster care for low-income patients: new lung cancer treatment models emerge january 13, 2018 2 lung cancer onclive mdedge medscape-article small cell lung cancer breast cancer medpagetoday non-small cell lung cancer clinicaltrials radiation therapy triple-negative breast cancer prostate cancer multiple myeloma chronic obstructive pulmonary disease lymphomas leukemia melanoma metastatic breast cancer lymphoma diarrhea squamous cell carcinoma alopecia ovarian cancer menopause hodgkin lymphoma recent posts heplisav-b hepatitis b vaccine in treatment na(sqrroot) ve chronic lymphocytic leukemia (cll) and cll treated with bruton s-tyrosine kinase inhibitor (btk-i) genotype -phenotype correlation of pklr variants with pyruvate kinase, 2,3-diphosphglycerate and adenosine triphosphate activities in red blood cells of people with sickle cell disease trial evaluating mgta-456 in patients with high-risk malignancy clinical evaluation of the “nicu clinical decision support dashboard” – chmco clinical evaluation of the “nicu clinical decision support dashboard” – mhsb social recent posts heplisav-b hepatitis b vaccine in treatment na(sqrroot) ve chronic lymphocytic leukemia (cll) and cll treated with bruton s-tyrosine kinase inhibitor (btk-i) october 3, 2018 genotype -phenotype correlation of pklr variants with pyruvate kinase, 2,3-diphosphglycerate and adenosine triphosphate activities in red blood cells of people with sickle cell disease october 3, 2018 trial evaluating mgta-456 in patients with high-risk malignancy october 3, 2018 clinical evaluation of the “nicu clinical decision support dashboard” – chmco october 3, 2018 clinical evaluation of the “nicu clinical decision support dashboard” – mhsb october 3, 2018 fibrin melanoma axillary node study in patients with melanoma october 3, 2018 dose escalation study of preoperative sbrt for high risk prostate cancer october 3, 2018 nivolumab after surgery and chemotherapy in treating patients with stage ib-iiia non-small cell lung cancer (an alchemist treatment trial) october 3, 2018 pioneering radiotherapy machine is a ‘dream come true’: 5 questions october 3, 2018 better therapy, not earlier diagnosis, explains improved rcc survival october 2, 2018 @oncologypub better therapy, not earlier diagnosis, explains improved rcc survival - https://t.co/u9nhdkbgml https://t.co/cb2w6wjdmt 3 hours ago vaccine tx shows promise in her2-positive cancers - https://t.co/jvp6kqy8if https://t.co/a11yrsjplj 4 hours ago dog sniffs out lung cancer, but something’s fishy - https://t.co/kbhzkkpxxm https://t.co/fdaaqv8w8l 2018/10/02 pazopanib shows promise in rare cancer syndrome - https://t.co/smgu5gy1uk https://t.co/nxbjs4bqsv 2018/10/02 rt @onclive : we just had the pleasure of interviewing jill o'donnell-tormey, phd, ceo and director of scientific affairs at @cancerresearch… 2018/10/01 oncology.pub oncology.pub was created as a way to manage the mountain of cancer research and clinical oncology news. we’ve aggregated the top hcp oncology news and research sources to bring you the latest in oncology. powered by mdlink | privacy policy

Analyse PopURL pour oncology.pub

https://oncology.pub/t/onclive
https://oncology.pub/lung-cancer-clinical-trial/clinical-evaluation-of-the-nicu-clinical-decision-support-dashboard-mhsb
https://oncology.pub/t/lymphomas
https://oncology.pub/lung-cancer-clinical-trial/genotype-phenotype-correlation-of-pklr-variants-with-pyruvate-kinase-23-diphosphglycerate-and-adenosine-triphosphate-activities-in-red-blood-cells-of-people-with-sickle-cell-disease
https://oncology.pub/t/lymphoma
https://oncology.pub/#tab1
https://oncology.pub/t/diarrhea
https://oncology.pub/immuno-oncology
https://oncology.pub/lung-cancer/adherence-to-follow-up-lung-cancer-screening-not-optimal-2
https://oncology.pub/t/breast-cancer
https://oncology.pub/t/alopecia
https://oncology.pub/breast-cancer/transformational-results-in-squamous-cell-lung-cancer
https://oncology.pub/gynecologic-cancer
https://oncology.pub/renal-cell-carcinoma/will-quad-therapy-become-the-new-standard-in-myeloma-2#respond
https://oncology.pub/breast-cancer/breast-cancer-risk-in-type-2-diabetes-related-to-adiposity#respond

Informations Whois

Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;

Domain Name: oncology.pub
Registry Domain ID: 35ef6cbc16c2470d92108a1f0a272f7e-DONUTS
Registrar WHOIS Server: whois.uniregistrar.com
Registrar URL: http://uniregistrar.com
Updated Date: 2018-10-03T17:02:45Z
Creation Date: 2018-08-05T01:55:17Z
Registry Expiry Date: 2019-08-05T01:55:17Z
Registrar: Uniregistrar Corp
Registrar IANA ID: 1659
Registrar Abuse Contact Email: abuse@uniregistry.com
Registrar Abuse Contact Phone: +1.3457496263
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Registry Registrant ID: REDACTED FOR PRIVACY
Registrant Name: REDACTED FOR PRIVACY
Registrant Organization:
Registrant Street: REDACTED FOR PRIVACY
Registrant City: REDACTED FOR PRIVACY
Registrant State/Province: Grand Cayman
Registrant Postal Code: REDACTED FOR PRIVACY
Registrant Country: KY
Registrant Phone: REDACTED FOR PRIVACY
Registrant Phone Ext: REDACTED FOR PRIVACY
Registrant Fax: REDACTED FOR PRIVACY
Registrant Fax Ext: REDACTED FOR PRIVACY
Registrant Email: Please query the RDDS service of the Registrar of Record identified in this output for information on how to contact the Registrant, Admin, or Tech contact of the queried domain name.
Registry Admin ID: REDACTED FOR PRIVACY
Admin Name: REDACTED FOR PRIVACY
Admin Organization: REDACTED FOR PRIVACY
Admin Street: REDACTED FOR PRIVACY
Admin City: REDACTED FOR PRIVACY
Admin State/Province: REDACTED FOR PRIVACY
Admin Postal Code: REDACTED FOR PRIVACY
Admin Country: REDACTED FOR PRIVACY
Admin Phone: REDACTED FOR PRIVACY
Admin Phone Ext: REDACTED FOR PRIVACY
Admin Fax: REDACTED FOR PRIVACY
Admin Fax Ext: REDACTED FOR PRIVACY
Admin Email: Please query the RDDS service of the Registrar of Record identified in this output for information on how to contact the Registrant, Admin, or Tech contact of the queried domain name.
Registry Tech ID: REDACTED FOR PRIVACY
Tech Name: REDACTED FOR PRIVACY
Tech Organization: REDACTED FOR PRIVACY
Tech Street: REDACTED FOR PRIVACY
Tech City: REDACTED FOR PRIVACY
Tech State/Province: REDACTED FOR PRIVACY
Tech Postal Code: REDACTED FOR PRIVACY
Tech Country: REDACTED FOR PRIVACY
Tech Phone: REDACTED FOR PRIVACY
Tech Phone Ext: REDACTED FOR PRIVACY
Tech Fax: REDACTED FOR PRIVACY
Tech Fax Ext: REDACTED FOR PRIVACY
Tech Email: Please query the RDDS service of the Registrar of Record identified in this output for information on how to contact the Registrant, Admin, or Tech contact of the queried domain name.
Name Server: eva.ns.cloudflare.com
Name Server: jake.ns.cloudflare.com
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2018-10-28T02:34:39Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

Terms of Use: Donuts Inc. provides this Whois service for information purposes, and to assist persons in obtaining information about or related to a domain name registration record. Donuts does not guarantee its accuracy. Users accessing the Donuts Whois service agree to use the data only for lawful purposes, and under no circumstances may this data be used to: a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the registrar’s own existing customers and b) enable high volume, automated, electronic processes that send queries or data to the systems of Donuts or any ICANN-accredited registrar, except as reasonably necessary to register domain names or modify existing registrations. When using the Donuts Whois service, please consider the following: The Whois service is not a replacement for standard EPP commands to the SRS service. Whois is not considered authoritative for registered domain objects. The Whois service may be scheduled for downtime during production or OT&E maintenance periods. Queries to the Whois services are throttled. If too many queries are received from a single IP address within a specified time, the service will begin to reject further queries for a period of time to prevent disruption of Whois service access. Abuse of the Whois system through data mining is mitigated by detecting and limiting bulk query access from single sources. Where applicable, the presence of a [Non-Public Data] tag indicates that such data is not made publicly available due to applicable data privacy laws or requirements. Should you wish to contact the registrant, please refer to the Whois records available through the registrar URL listed above. Access to non-public data may be provided, upon request, where it can be reasonably confirmed that the requester holds a specific legitimate interest and a proper legal basis for accessing the withheld data. Access to this data can be requested by submitting a request via the form found at https://donuts.domains/about/policies/whois-layered-access/ Donuts Inc. reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.

SERVERS

  SERVER pub.whois-servers.net

  ARGS oncology.pub

  PORT 43

  TYPE domain
RegrInfo
DOMAIN

  NAME oncology.pub

NSERVER

  EVA.NS.CLOUDFLARE.COM 173.245.58.114

  JAKE.NS.CLOUDFLARE.COM 173.245.59.122

  REGISTERED yes

Erreurs

La liste suivante vous montre les fautes d'orthographe possibles des internautes pour le site Web recherché.